First U.S. Clinical Laparoscopic Procedure with New Percuvance®
System Performed at the Duke Center for Metabolic and Weight Loss Surgery
Teleflex Launches Ambitious Efforts to Accelerate Growing Acceptance
Worldwide of Percutaneous Laparoscopy Now Performed in 14 Countries
WAYNE, Pa.--(BUSINESS WIRE)--Aug. 15, 2016--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care and surgery, has announced today that it
has officially launched its second-generation Percuvance® Percutaneous
Surgical System and that the first clinical laparoscopic procedures in
the U.S. using the system were performed at the Duke Center for
Metabolic and Weight Loss Surgery. Teleflex’s latest advance in
percutaneous laparoscopy is more versatile and enables procedures to be
even less invasive than its first-generation system while delivering the
performance of 5 mm laparoscopic devices commonly used in minimally
invasive surgeries (MIS) with less trauma.
The initial sleeve gastrectomy, Roux-en-Y gastric bypass, and
laparoscopic gastric band removal procedures were performed by Dr. Dana
D. Portenier* and his team. Dr. Portenier is the Chief of General
Surgery at Duke Regional Hospital and the Division Chief at the Duke
Center for Metabolic and Weight Loss Surgery.
“These are increasingly common but often challenging procedures,” said
Dr. Portenier. “Our experiences with the new system are consistent with
other clinical studies, which showed that its handling and functionality
were similar to standard 5-mm laparoscopic instrumentation. Further
research will determine whether the system’s smaller incisions could
potentially demonstrate improvements in patient pain, cosmesis, and
satisfaction.”
The second-generation, 2.9 mm Percuvance System features additional
interchangeable 5mm tool tips and a new quick-connect system to
facilitate fast and secure tool-tip changes outside of the body. The
system has the performance and versatility for use in common and
advanced general laparoscopic procedures, including laparoscopic
cholecystectomy, upper gastrointestinal, gastric, bariatric, colorectal
and hernia. It enables surgeons to eliminate one or more additional
trocars from their laparoscopic procedures versus the first-generation
device while delivering the outcomes and performance they expect from
their traditional laparoscopic devices.
The first generation Percuvance System has been used by more than 150
surgeons in the U.S. and EMEA since Teleflex implemented a limited
release of the first-generation system in March 2015. The
second-generation Percuvance device recently received FDA clearance and
CE Mark approval. During the next month, a series of surgical procedures
with the new Percuvance System will be conducted at other leading
institutions in New York, Texas, Florida and California by surgeons with
experience using the first-generation system.
“Our second-generation Percuvance System represents a significant
advancement in the ongoing and perpetual evolution of minimally invasive
surgery and is demonstrative of Teleflex’s unwavering commitment to
innovation,” said John Tushar, President and General Manager of Teleflex
Surgical. “We are encouraged by surgeons’ enthusiastic response to our
percutaneous surgical devices and are optimistic the new Percuvance
System will become a new standard of care in laparoscopic surgery.”
Teleflex is ramping up its sales and marketing efforts to familiarize
surgeons worldwide with the unique performance capabilities and benefits
of the 2.9 mm Percuvance System.
Percutaneous Laparoscopy: The next stage in the evolution of MIS
Traditional laparoscopic surgery revolutionized surgical practices more
than 30 years ago, and approximately 3 million laparoscopic procedures
are performed each year in the US1. Since the early 2000s,
new technologies and devices have been introduced with the goal of
making these surgeries increasingly less invasive. None, however, has
yet to become widely accepted in general practice for common
laparoscopic procedures.
Percutaneous laparoscopy is a new category of laparoscopic surgery
promoted by Teleflex to overcome the barriers that slowed widespread
acceptance of other approaches. In developing the new Percuvance System,
Teleflex listened to surgeons who said they wanted:
-
Even less invasive surgical practices that do not compromise
performance
-
Reduced trauma and scarring
-
A device that didn’t require them to learn a new, complicated surgical
technique.
“No matter what the surgery, patients generally prefer and are more
satisfied with smaller incisions,” said Dr. Chan W. Park†,
Assistant Professor of Surgery at Duke University School of Medicine and
a surgeon at the Duke Center for Metabolic and Weight Loss Surgery. “The
development of new options for less invasive surgery that may also
minimize discomfort for patients always represents a step forward in
clinical care.”
The Percuvance System has a short learning curve and requires few
adjustments to surgeons’ current techniques. In addition, it does not
have the high costs associated with capital, service and fully
disposable technologies.
About the Percuvance® System
Teleflex’s Percuvance® Percutaneous Surgical System is a family of
instruments used to perform laparoscopic procedures. It includes
components that introduce a variety of instrument configurations into
the abdominal cavity and requires a smaller incision site than
traditional laparoscopic surgery. It offers reusable handles and seven
disposable 5 mm interchangeable tool tips, which include graspers,
scissors, dissector, electrocautery tools, and a Weck® Hem-o-lok®
Polymer Ligation Clip Applier. Unlike some other laparoscopic devices,
the Percuvance® System affords a percutaneous insertion into the patient
without the use of an insertion trocar. The Percuvance® Percutaneous
Surgical System with 5 mm attachments is indicated for the means to
penetrate soft tissue to access certain areas of the abdomen. The
systems are used to grasp, manipulate, cut, cauterize, and deliver
Hem-o-lok System ligating clips to soft tissue during laparoscopic
surgery.
Click
here for animated video Teleflex.com/Percuvance
Teleflex Portfolio of Percutaneous Solutions
The Percuvance System complements another key product, the MiniLap®
Percutaneous Surgical System, in Teleflex’s growing portfolio of
innovative yet practical solutions for percutaneous laparoscopy. The
MiniLap System provides delivery and function through fully integrated
and disposable 2.3 and 2.4 mm devices. Like the Percuvance System, the
MiniLap System does not require a trocar for initial access and makes
minimally invasive procedures even less invasive for procedures where
common retraction, manipulation, and monopolar energy are required.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
MiniLap, Percuvance, Rüsch, Weck, and Hem-o-Lok are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates, in the
U.S. and/or other countries. © 2016 Teleflex Incorporated. All rights
reserved. MC-002526
References:
1 Source: Millennium Research Group, Inc, RPUS30LA13 |
November 2014, US MARKETS FOR LAPAROSCOPIC DEVICES 2015, p30, figure 4.
*Dr. Dana Portenier is a paid consultant of Teleflex.
†Dr.
Chan Park is a paid consultant of Teleflex.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160815005047/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
or
Media
Contact:
Sam Brown Inc.
Mike Beyer, 312-961-2502
mikebeyer@sambrown.com